Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.

L Sarmati1, E Nicastri, M Montano

  • 1Department of Public Health, University of Rome Tor Vergata, Rome, Italy.

Journal of Medical Virology
|February 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox.

AIDS and behavior·2026
Same author

Bundibugyo virus disease: transmission dynamics, infectiousness and viral persistence.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Most Stringent Bound on Electron Neutrino Mass Obtained with a Scalable Low-Temperature Microcalorimeter Array.

Physical review letters·2025
Same author

Eosinophilic cytokines and small airway dysfunction in women with COPD: correlation with exposure to biomass smoke versus tobacco smoking.

IJTLD open·2025
Same author

Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists' awareness.

JAC-antimicrobial resistance·2025
Same journal

Torque Teno Virus Dynamics in Plasma and BAL of COVID-19 ARDS Patients With and Without ECMO.

Journal of medical virology·2026
Same journal

Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study.

Journal of medical virology·2026
Same journal

The Impact of Admission Viral Load and Inflammatory Markers on Mortality and Prognosis in Crimean-Congo Hemorrhagic Fever.

Journal of medical virology·2026
Same journal

A One-Pot CRISPR-Cas12b Assay for Rapid Detection of Human Adenovirus Serotypes 3 and 7.

Journal of medical virology·2026
Same journal

Metabolic and Immunological Trajectories and Virological Outcomes of Ainuovirine-Based Antiretroviral Therapy: A 48-Week Longitudinal Cohort Study in Treatment-Naïve Adults.

Journal of medical virology·2026
Same journal

Favipiravir Is Associated With Reduced 28-Day Mortality in Severe Fever With Thrombocytopenia Syndrome: A Multicenter Propensity Score-Matched Study.

Journal of medical virology·2026
See all related articles

HIV strains from patients failing highly active antiretroviral therapy (HAART) showed reduced replication capacity after treatment changes. This impairment correlated with treatment response and drug resistance mutations, potentially explaining persistent immune recovery.

Area of Science:

  • Virology
  • Immunology
  • Antiretroviral Therapy Research

Background:

  • Highly active antiretroviral therapy (HAART) is crucial for managing HIV infection.
  • Patients failing HAART may exhibit varying responses, impacting viral load and immune status.
  • Understanding HIV replication capacity is key to optimizing treatment strategies.

Purpose of the Study:

  • To longitudinally assess the replication capacity of HIV strains in patients failing HAART.
  • To investigate the correlation between HIV replication capacity, treatment response, and drug resistance mutations.
  • To explore the implications of impaired viral replication on immune recovery in HAART-failing patients.

Main Methods:

  • Longitudinal study of 18 patients failing HAART, with therapy changes guided by genotypic resistance testing.

Related Experiment Videos

  • Measurement of HIV replication capacity at baseline and 12 months post-therapy change.
  • Categorization of patients into immune responders and non-responders based on CD4 cell count recovery.
  • Analysis of drug resistance mutations, particularly in the protease gene.

    • Main Results:

    • All patients showed a decrease in HIV replication capacity after 12 months of modified HAART.
    • HIV replication capacity significantly decreased in both immune responders and non-responders.
    • A statistically significant difference in HIV replication capacity was observed between the groups at 12 months (P<0.03).
    • Increased drug resistance mutations, including M36I, were noted, especially in immune responders.

    Conclusions:

    • HIV strains from patients failing HAART exhibit progressively impaired replication capacity.
    • Impaired viral replication correlates with discordant viro-immunological responses and acquisition of resistance mutations.
    • Reduced HIV replication capacity may contribute to persistent immune recovery despite treatment failure.